Clinical Trial Update: S9304A Study of Protein Expression in Tumor Tissue Samples From Patients With Stage II or Stage III Rectal Cancer Enrolled in Clinical Trial SWOG-9304

View source ↗

Summary

SWOG-9304A, a protein-expression study in tumor tissue from patients with stage II or III rectal cancer enrolled in SWOG-9304, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Colorectal Cancer | Status: COMPLETED